BANCOLOMBIA S.A. TO DELIST NOTES FROM THE NEW YORK STOCK EXCHANGE
Codexis (NASDAQ: CDXS), a provider of enzymatic solutions for therapeutics manufacturing, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The event will take place from June 3-5, 2025 in New York.
The company's management will engage in a fireside chat on June 4, 2025, at 3:10 pm ET. Investors can access a live webcast of the presentation through Codexis's investor relations website, with a replay available for 90 days after the event.
Codexis (NASDAQ: CDXS), fornitore di soluzioni enzimatiche per la produzione di terapie, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. L'evento si svolgerà dal 3 al 5 giugno 2025 a New York.
La direzione dell'azienda parteciperà a un incontro informale il 4 giugno 2025 alle 15:10 ET. Gli investitori potranno seguire la presentazione in diretta streaming tramite il sito web delle relazioni con gli investitori di Codexis, con una replica disponibile per 90 giorni dopo l'evento.
Codexis (NASDAQ: CDXS), proveedor de soluciones enzimáticas para la fabricación de terapias, ha anunciado su participación en la próxima Conferencia Global de Salud de Jefferies. El evento se llevará a cabo del 3 al 5 de junio de 2025 en Nueva York.
La dirección de la empresa participará en una charla informal el 4 de junio de 2025 a las 3:10 pm ET. Los inversores podrán acceder a una transmisión en vivo de la presentación a través del sitio web de relaciones con inversores de Codexis, con una repetición disponible durante 90 días después del evento.
Codexis (NASDAQ: CDXS)는 치료제 제조를 위한 효소 솔루션 제공업체로서 다가오는 Jefferies 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 행사는 2025년 6월 3일부터 5일까지 뉴욕에서 개최됩니다.
회사 경영진은 2025년 6월 4일 오후 3시 10분(동부시간)에 파이어사이드 채팅에 참여할 예정입니다. 투자자들은 Codexis 투자자 관계 웹사이트를 통해 생중계 시청이 가능하며, 행사 후 90일간 다시보기 서비스도 제공됩니다.
Codexis (NASDAQ : CDXS), fournisseur de solutions enzymatiques pour la fabrication de produits thérapeutiques, a annoncé sa participation à la prochaine conférence mondiale Jefferies Global Healthcare. L'événement aura lieu du 3 au 5 juin 2025 à New York.
La direction de l'entreprise participera à une discussion informelle le 4 juin 2025 à 15h10 ET. Les investisseurs pourront accéder à une diffusion en direct de la présentation via le site des relations investisseurs de Codexis, avec un replay disponible pendant 90 jours après l'événement.
Codexis (NASDAQ: CDXS), ein Anbieter enzymatischer Lösungen für die Herstellung von Therapeutika, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angekündigt. Die Veranstaltung findet vom 3. bis 5. Juni 2025 in New York statt.
Das Management des Unternehmens wird am 4. Juni 2025 um 15:10 Uhr ET an einem Fireside-Chat teilnehmen. Investoren können die Präsentation live über die Investor-Relations-Website von Codexis verfolgen, eine Aufzeichnung steht für 90 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 3-5, 2025, in New York, New York.
Management will participate in a fireside chat on Wednesday, June 4, 2025, at 3:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
FAQ
When is Codexis (CDXS) presenting at the Jefferies Global Healthcare Conference 2025?
Where can I watch Codexis's (CDXS) Jefferies Conference presentation?
How long will the replay of Codexis's (CDXS) Jefferies Conference presentation be available?
What is the date of the 2025 Jefferies Global Healthcare Conference?
